Skip to main content
2025 CRT Conference Main banner
Back

William T. Abraham, MD

Professor of Medicine
The Ohio State University
Columbus, Ohio, United States

Dr. Abraham earned his MD from Harvard Medical School and completed Internal Medicine residency and fellowships in Cardiovascular Disease and Advanced Heart Failure/Transplant Cardiology at the University of Colorado. He is a Professor of Internal Medicine, Physiology, and Cell Biology and College of Medicine Distinguished Professor at The Ohio State University. He has been recognized as one of the “Best Doctors in America” for 22 consecutive years. His research focuses on new drug and device devleopment for heart failure (HF). His work has led to the approval and adoption of several new therapies for HF, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, transcatheter mitral valve repair, and baroreflex activation therapy.

Disclosure(s): Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); AquaPass: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); CVRx: Consultant (Ongoing); Innoventric: Consultant (Ongoing); JNJ V-Wave: Salary (Ongoing); SCPharmaceuticals: Board of Directors (Ongoing); Vectorious Medtech: Consultant (Ongoing); White Swell: Consultant (Ongoing); Zoll Respicardia: Consultant (Ongoing)

Presentation(s):

Email William